Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | Erlotinib | UHNBreast | pan-cancer | AAC | -0.13 | 0.6 |
mRNA | CAL-101 | GDSC1000 | pan-cancer | AAC | 0.015 | 0.7 |
mRNA | BRD-K49290616 | CTRPv2 | pan-cancer | AAC | 0.034 | 0.7 |
mRNA | (5Z)-7-Oxozeaenol | GDSC1000 | pan-cancer | AAC | 0.014 | 0.7 |
mRNA | neratinib | CTRPv2 | pan-cancer | AAC | 0.017 | 0.7 |
mRNA | EHT 1864 | GDSC1000 | pan-cancer | AAC | 0.015 | 0.7 |
mRNA | BEC | CTRPv2 | pan-cancer | AAC | 0.032 | 0.7 |
mRNA | GDC-0449 | GDSC1000 | pan-cancer | AAC | 0.016 | 0.7 |
mRNA | Bosutinib | FIMM | pan-cancer | AAC | 0.19 | 0.7 |
mRNA | KU-55933 | CTRPv2 | pan-cancer | AAC | 0.016 | 0.7 |